Denmark to host AI supercomputer for drug research

The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of discovering new medicines and treatments. CNN reports that the supercomputer, named Gefion, is expected to be ready for pilot projects before the end of the year and will be housed in Denmark’s National Center for AI Innovation.